GB1401565A - Vaccine for neonatal calf diarrhoea - Google Patents

Vaccine for neonatal calf diarrhoea

Info

Publication number
GB1401565A
GB1401565A GB4925373A GB4925373A GB1401565A GB 1401565 A GB1401565 A GB 1401565A GB 4925373 A GB4925373 A GB 4925373A GB 4925373 A GB4925373 A GB 4925373A GB 1401565 A GB1401565 A GB 1401565A
Authority
GB
United Kingdom
Prior art keywords
vaccine
bovine
virus
coronavirus
diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4925373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of GB1401565A publication Critical patent/GB1401565A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

1401565 Calf diarrhea vaccine UNIVERSITY OF NEBRASKA REGENTS OF 23 Oct 1973 [30 Oct 1972] 49253/73 Heading A5B A calf diarrhea vaccine comprises an attenuated or inactivated coronavirus-like calf diarrhea virus. The vaccine may be in the form of a combination vaccine comprising inactivated coronavirus and reovirus, both of which are prepared by inactivating a live virus, either unaaatenuated or attenuated, by chamicals, radiation or heat. Coronavirus can also be combined with bovine adenovirus, bovine virus diarrhea, or other bovine pathogens such as E. Coli or clostridia sp.
GB4925373A 1972-10-30 1973-10-23 Vaccine for neonatal calf diarrhoea Expired GB1401565A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (1)

Publication Number Publication Date
GB1401565A true GB1401565A (en) 1975-07-16

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4925373A Expired GB1401565A (en) 1972-10-30 1973-10-23 Vaccine for neonatal calf diarrhoea

Country Status (17)

Country Link
JP (3) JPS5817169B2 (en)
AR (1) AR200155A1 (en)
AU (1) AU476160B2 (en)
BE (1) BE806568A (en)
CA (1) CA1019675A (en)
CH (1) CH596315A5 (en)
DD (1) DD110517A5 (en)
DE (1) DE2354324C2 (en)
ES (1) ES419996A1 (en)
FI (1) FI52740C (en)
FR (1) FR2204405B1 (en)
GB (1) GB1401565A (en)
HU (1) HU168486B (en)
IE (1) IE38423B1 (en)
NL (1) NL7314293A (en)
SE (1) SE419500B (en)
ZA (1) ZA738329B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246680A1 (en) * 1986-04-21 1987-11-25 Akzo Nobel N.V. Combined vaccine
WO1990001337A1 (en) * 1988-08-03 1990-02-22 Institute For Animal Health Limited Vaccine
US6416764B1 (en) 1988-08-03 2002-07-09 Vericore Limited Vaccine
US10808227B2 (en) 2015-11-06 2020-10-20 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (en) * 1983-07-30 1985-02-23 株式会社　協立双葉自動機 Labeling machine with container rotation speed adjustment device
JPH0518338Y2 (en) * 1985-12-27 1993-05-17
JPH08786B2 (en) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 Bovine coronavirus infectious disease vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (en) * 1969-11-28 1971-05-25 Mebus Charles A CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246680A1 (en) * 1986-04-21 1987-11-25 Akzo Nobel N.V. Combined vaccine
WO1990001337A1 (en) * 1988-08-03 1990-02-22 Institute For Animal Health Limited Vaccine
GB2239799A (en) * 1988-08-03 1991-07-17 Animal Health Inst Vaccine
GB2239799B (en) * 1988-08-03 1992-01-22 Animal Health Inst Vaccine
US6416764B1 (en) 1988-08-03 2002-07-09 Vericore Limited Vaccine
US10808227B2 (en) 2015-11-06 2020-10-20 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Also Published As

Publication number Publication date
DE2354324A1 (en) 1974-05-09
JPS5531058A (en) 1980-03-05
JPS6124370B2 (en) 1986-06-10
DD110517A5 (en) 1974-12-20
FR2204405A1 (en) 1974-05-24
JPS5817169B2 (en) 1983-04-05
CH596315A5 (en) 1978-03-15
NL7314293A (en) 1974-05-02
AU6177473A (en) 1975-04-24
BE806568A (en) 1974-04-26
AU476160B2 (en) 1976-09-16
JPS5757449B2 (en) 1982-12-04
JPS57131726A (en) 1982-08-14
AR200155A1 (en) 1974-10-24
SE419500B (en) 1981-08-10
DE2354324C2 (en) 1982-06-03
ZA738329B (en) 1974-09-25
IE38423B1 (en) 1978-03-15
FR2204405B1 (en) 1977-01-28
HU168486B (en) 1976-05-28
CA1019675A (en) 1977-10-25
IE38423L (en) 1974-04-30
FI52740C (en) 1977-11-10
JPS4980230A (en) 1974-08-02
FI52740B (en) 1977-08-01
ES419996A1 (en) 1976-08-01

Similar Documents

Publication Publication Date Title
IT1190792B (en) PROCEDURE FOR PREPARING BLOOD COAGULANT ENZYME COMPOSITIONS
DK26081A (en) GENETICALLY WEAKED BACTERIA VACCINES WITH MULTIPLE MUTATIONS OF THE SAME PHENOTYPE
NZ314585A (en) Method of treating H. Pylori associated gastroduodenal disease
GB1401565A (en) Vaccine for neonatal calf diarrhoea
SE7512828L (en) CALICIVIRUSVACCIN
TW340873B (en) Chicken anaemia agent vaccine
ES370327A1 (en) Orally administrable polyvalent vaccines for intestinal infections
DE3361138D1 (en) Ozone inactivated organisms as vaccines
FR2108935A1 (en) Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals
ES341918A1 (en) Improvements in the construction of mobile beam ovens. (Machine-translation by Google Translate, not legally binding)
NL300073I1 (en) Vaccine.
GB1036621A (en) Improvements in or relating to bacterial vaccines
SE7711433L (en) TRICYCLIC ASSOCIATIONS
GB949400A (en) Poliomyelitis vaccines
SU565653A1 (en) Method of preservation of bone tissue
GB1065899A (en) Improvements in or relating to martensitic,age hardening stainless steel
SU979504A1 (en) Strain of nag-phage 93, f-98 lysing nag-vibrous of the 0-8 serotype
ES279927A1 (en) Procedure for the preparation of a vaccine against foot-and-mouth disease (Machine-translation by Google Translate, not legally binding)
before Parliament et al. The Industrial Relations (Code of Practice) Order 1972
MOVEMENT Ol\1MONWEALTH COLLEGE: STUDENT ACTIVISM AND THE I SOUTHERN AGRICULTURAL LABOR MOVEMENT, 1923-1940
Saben Rapeseed meal as an energy and protein source for growing pigs
GB1323842A (en) Immunizing vaccine for the immunization of dogs against kennel cough
GB414639A (en) Improvements in and relating to a process for hardening wood which has been rendered easily flexible
GB1360838A (en) Preparation of an attenuated rubella virus and vaccine
Nicolas et al. Attempt of Vaccination Program Against Sheep Salmonellosis due to Salmonella abortus ovis.

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19931022